找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affect; Proceedings of the T Joel Morganroth,

[復(fù)制鏈接]
樓主: CLIP
31#
發(fā)表于 2025-3-27 00:49:39 | 只看該作者
32#
發(fā)表于 2025-3-27 03:13:02 | 只看該作者
33#
發(fā)表于 2025-3-27 06:19:24 | 只看該作者
What Should be Required for FDA Approvability of a New Antihypertensive Drug? What is the FDA’s Viewe fairly clear. Antihypertensive drugs are approved on the basis of a demonstrated ability to lower blood pressure to a reasonable degree and a reasonably complete characterization of a drug’s pharmacokinetic and pharmacodynamic properties, with particular emphasis on dose-response and on patient ch
34#
發(fā)表于 2025-3-27 12:24:55 | 只看該作者
35#
發(fā)表于 2025-3-27 15:36:50 | 只看該作者
36#
發(fā)表于 2025-3-27 20:24:27 | 只看該作者
37#
發(fā)表于 2025-3-27 21:56:05 | 只看該作者
0166-9842 al and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering
38#
發(fā)表于 2025-3-28 03:02:29 | 只看該作者
39#
發(fā)表于 2025-3-28 06:40:30 | 只看該作者
What Should be Required for FDA Approvability of a New Antihypertensive Drug? What is the FDA’s Viewaracteristics that can alter this response. We have not, up to now, sought evidence of diminished end-organ damage or mortality for each new agent, relying instead on the past studies that showed such benefits of lowering blood pressure.
40#
發(fā)表于 2025-3-28 13:46:51 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 04:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
桐庐县| 平谷区| 鄂伦春自治旗| 花莲市| 会泽县| 泸水县| 迭部县| 平陆县| 同心县| 石门县| 深圳市| 喀喇沁旗| 泸水县| 博客| 泰宁县| 怀柔区| 长汀县| 惠来县| 庄浪县| 集安市| 惠东县| 凤山市| 温宿县| 南昌县| 武胜县| 平山县| 新竹市| 长春市| 新化县| 民丰县| 保德县| 睢宁县| 都江堰市| 车险| 恭城| 会宁县| 黎川县| 紫阳县| 抚顺市| 娱乐| 新疆|